Patents by Inventor Keita KANKI

Keita KANKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitory effect of low molecular weight compound on cancer and fibrosis
    Patent number: 11213527
    Abstract: A novel therapeutic drug for malignant tumors, cancer stem cells, or fibrosis is obtained. A therapeutic drug for malignant tumors or cancer stem cells is used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof. Alternatively, a therapeutic drug for fibrosis can be used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: January 4, 2022
    Assignees: National University Corporation Tottori University, KanonCure, Inc.
    Inventors: Goshi Shiota, Noriko Itaba, Keita Kanki, Kenzo Seto, Hiroki Shimizu, Yohei Kouno, Shinya Kunita, Zyunya Adumi, Tomohiko Sakabe, Kenichiro Abe, Minoru Morimoto, Hiroyuki Oka
  • INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS
    Publication number: 20210386747
    Abstract: A novel therapeutic drug for malignant tumors, cancer stem cells, or fibrosis is obtained. A therapeutic drug for malignant tumors or cancer stem cells is used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof. Alternatively, a therapeutic drug for fibrosis can be used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 16, 2021
    Inventors: Goshi SHIOTA, Noriko ITABA, Keita KANKI, Kenzo SETO, Hiroki SHIMIZU, Yohei KOUNO, Shinya KUNITA, Zyunya ADUMI, Tomohiko SAKABE, Kenichiro ABE, Minoru MORIMOTO, Hiroyuki OKA
  • INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS
    Publication number: 20180028536
    Abstract: A novel therapeutic drug for malignant tumors, cancer stem cells, or fibrosis is obtained. A therapeutic drug for malignant tumors or cancer stem cells is used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof. Alternatively, a therapeutic drug for fibrosis can be used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof.
    Type: Application
    Filed: March 25, 2015
    Publication date: February 1, 2018
    Inventors: Goshi SHIOTA, Noriko ITABA, Keita KANKI, Kenzo SETO, Hiroki SHIMIZU, Yohei KOUNO, Shinya KUNITA, Zyunya ADUMI, Tomohiko SAKABE, Kenichiro ABE, Minoru MORIMOTO, Hiroyuki OKA